This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Many men with prostate cancer die from causes other than their index malignancy. Comorbid cardiovascular disease (CVD) is strongly associated with cause of death in men in prostate cancer, raising the possibility that prostate cancer or its treatment may increase CVD risk. Insulin resistance is an independent risk factor for CVD. Androgen deprivation therapy increases fat mass, serum triglyceride levels, and fasting plasma insulin levels. These treatment-related adverse effects are consistent with the syndrome of insulin resistance. The primary objective of this study is to prospectively evaluate changes in insulin sensitivity during androgen deprivation therapy.
Showing the most recent 10 out of 945 publications